These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37338985)

  • 1. Evaluating Model Specification When Using the Parametric G-Formula in the Presence of Censoring.
    Chiu YH; Wen L; McGrath S; Logan R; Dahabreh IJ; Hernán MA
    Am J Epidemiol; 2023 Nov; 192(11):1887-1895. PubMed ID: 37338985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the g-null Paradox.
    McGrath S; Young JG; Hernán MA
    Epidemiology; 2022 Jan; 33(1):114-120. PubMed ID: 34711734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric g-formula implementations for causal survival analyses.
    Wen L; Young JG; Robins JM; Hernán MA
    Biometrics; 2021 Jun; 77(2):740-753. PubMed ID: 32588909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.
    Murray EJ; Robins JM; Seage GR; Freedberg KA; Hernán MA
    Am J Epidemiol; 2017 Jul; 186(2):131-142. PubMed ID: 28838064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation from a known Cox MSM using standard parametric models for the g-formula.
    Young JG; Tchetgen Tchetgen EJ
    Stat Med; 2014 Mar; 33(6):1001-14. PubMed ID: 24151138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Nested Cumulative Failure Time Models to Estimate the Effects of Interventions.
    Picciotto S; Hernán MA; Page JH; Young JG; Robins JM
    J Am Stat Assoc; 2012; 107(499):. PubMed ID: 24347749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted maximum likelihood based causal inference: Part I.
    van der Laan MJ
    Int J Biostat; 2010; 6(2):Article 2. PubMed ID: 21969992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved multiply robust estimator for the average treatment effect.
    Wang C; Wei K; Huang C; Yu Y; Qin G
    BMC Med Res Methodol; 2023 Oct; 23(1):231. PubMed ID: 37821829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Left-Censored Data Through Substitution, Parametric, Semi-parametric, and Nonparametric Methods: A Simulation Study.
    Tekindal MA; Erdoğan BD; Yavuz Y
    Interdiscip Sci; 2017 Jun; 9(2):153-172. PubMed ID: 26590921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips.
    Shinozaki T; Suzuki E
    J Epidemiol; 2020 Sep; 30(9):377-389. PubMed ID: 32684529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal Methods for Observational Research: A Primer.
    Almasi-Hashiani A; Nedjat S; Mansournia MA
    Arch Iran Med; 2018 Apr; 21(4):164-169. PubMed ID: 29693407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
    Mertens K; Vansteelandt S
    Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Causal Inference Methods in the Analysis of Observational Neurosurgical Data: G-Formula and Marginal Structural Model.
    Kawahara T; Shiba K; Tsuchiya A
    World Neurosurg; 2022 May; 161():310-315. PubMed ID: 35505549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-computation and doubly robust standardisation for continuous-time data: A comparison with inverse probability weighting.
    Chatton A; Borgne FL; Leyrat C; Foucher Y
    Stat Methods Med Res; 2022 Apr; 31(4):706-718. PubMed ID: 34861799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects.
    Blanche PF; Holt A; Scheike T
    Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.